Package Leaflet: Information for the Patient
CUVEFILM10 mg/ml cutaneous solution
Chlorhexidine digluconate
Read the package leaflet carefully before starting to use this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist.
Contents of the Package Leaflet
It is a medication for cutaneous use that contains chlorhexidine digluconate as the active ingredient. Chlorhexidine is an antiseptic that is applied to the skin.
It is indicated as an antiseptic for wounds and minor burns of the skin and as an antiseptic for the navel in newborns.
You should consult a doctor if it worsens or does not improve after 5 days.
Do not use CUVEFILM:
Warnings and precautions
Consult your doctor or pharmacist before starting to use CUVEFILM.
Children
Use with caution in neonates, especially in premature babies. CUVEFILM can cause chemical burns on the skin.
Consult with your doctor before using in children under 30 months.
Other medications and CUVEFILM
Use of CUVEFILM with other medications. Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
The use of several antiseptics at the same time or successively should be avoided, except with other cationic compounds.
It should not be used in combination or after the application of anionic soaps (soaps), acids, heavy metal salts, and iodine, so the skin should be rinsed well after cleaning.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and using machines
No effects on the ability to drive and use machines have been described after using CUVEFILM.
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
It is recommended to clean and dry the wound before applying CUVEFILM. Apply undiluted to the affected area, or to a gauze, one or two times a day. Do not perform more than two daily applications of the product.
If the symptoms worsen or do not improve after 5 days, consult your doctor.
If you use more CUVEFILM than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
Like all medications, this medication can cause side effects, although not everyone experiences them.
Other possible side effects, for which the frequency is unknown, are:
If you consider that any of the side effects you are experiencing is serious or if you notice any side effect not mentioned in this package leaflet, inform your doctor or pharmacist.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Store in the original packaging to protect it from light.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown away through the sewers or in the trash. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of CUVEFILM
Appearance of the product and contents of the packaging
Transparent, colorless, and odorless liquid.
It is presented in 25 ml and 50 ml PET bottles with a dropper cap made of polyethylene.
Marketing authorization holder and manufacturer
PHARMEX ADVANCED LABORATORIES, S.L.
Ctra. A-431 Km.19
14720 Almodóvar del Río (Córdoba)
Spain
Date of the last revision of this package leaflet: September2024
Updated and detailed information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)http://www.aemps.gob.es/